AI assistant
Sending…
ZEVRA THERAPEUTICS, INC. — Director's Dealing 2021
Sep 1, 2021
32811_dirs_2021-09-01_6490889f-6400-4065-9d76-f129aae62800.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: KEMPHARM, INC (KMPH)
CIK: 0001434647
Period of Report: 2021-09-01
Reporting Person: Clifton R. LaDuane (CFO, Secretary & Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-01 | Common Stock | P | 230 | $9.1050 | Acquired | 3580 | Direct |
More from ZEVRA THERAPEUTICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Interim / Quarterly Report
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 20
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2